MiMedx Enters Exclusive Distribution Agreement with Summit
MiMedx announced it has entered into an exclusive agreement with Summit Products Group to distribute three 510(k) cleared products that complement the company's Surgical & Wound product portfolio: Hydrelix, NovaForm, and G4Derm Plus. "We are excited to announce this distribution agreement with Summit to meaningfully expand our product offering with Hydrelix, NovaForm and G4Derm Plus. These are innovative xenograft and synthetic products that strengthen our ability to serve the Surgical & Wound markets. As the landscape of this market continues to evolve, MIMEDX remains a leader in supporting customers and their patients with proven products," stated Kim Moller, MIMEDX Chief Commercial Officer.
